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1. Introduction  
Liver biopsy has long been an important tool for assessing the degree of liver fibrosis. 
Currently, there are many reports and approaches to evaluate the staging of hepatic fibrosis 
by using noninvasive imaging methods. The main modalities are based on ultrasonography 
(US) and magnetic resonance imaging (MRI). Among these techniques, Transient 
Elastography (TE, Fibroscan) has taken a leading role in the noninvasive assessment of liver 
stiffness at current clinical medicine in Europe. The principal of TE is simple: TE measures the 
propagation speed of elastic shear wave within the liver parenchyma. The velocity of the wave 
propagation correlates directly to tissue stiffness; that is, the harder the tissue is, the faster the 
shear wave spread.  
In this chapter, we introduce a new US-based approach for non-invasive assessment of liver 
fibrosis using real-time tissue elastography (RTE) that can be performed simultaneously with 
conventional ultrasound probes during routine US examination. RTE is technically different 
from TE: echo signals representing tissue strain before and under mild compression are 
compared and analyzed. RTE was developed in Japan for the visual assessment of tissue 
elasticity integrated in a sonography machine. The technique is based on the Combined 
Autocorrelation Method that calculates the relative hardness of tissue rapidly from the degree 
of tissue distortion and displays this information as a color image [Shiina T, 2002]. The 
distortion of tissue is transferred to a color-coded image according to its magnitude and 
superimposed translucently on the conventional B-mode image. Such a simultaneous display 
of tissue elasticity and B-mode images enables us to evaluate the anatomical correspondence 
between these modalities. The RTE image is constructed by the amount of displacement of the 
reflected ultrasound echoes under compression. Although US-based elastography is unable to 
demonstrate physical elasticity directly, it shows the relative degree of tissue strain when 
subtle compression is applied. In hard tissue, the amount of displacement of the reflected 
ultrasound echoes is low, whereas, in soft tissue, the amount of displacement is high because 
soft tissue can be compressed more than hard tissue.  
This technology has already been proved to be diagnostically valuable in detecting space 
occupying lesions in the breast, prostate, and pancreas. In 2007, Friedrich-Rust applied this 
technique to measure liver stiffness and reported its usefulness for the detection of significant 
fibrosis (≧F2, area under the receiver operating characteristic curve; AUC 0.93) in combination 
with AST to platelet ratio index (APRI). In 2010, we reported that AUC for no significant 
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fibrosis (F0-1) was 0.89 and 0.92 in RTE and TE, respectively, and AUC for cirrhosis (F4) was 
0.93 and 0.95 in RTE and TE, respectively, in 101 patients with chronic hepatitis C. 
We report here an update of the RTE system as a tool for the noninvasive assessment of liver 
stiffness together with an overview of recent advancement in this area in the literature. 
 
 
Fig. 1. The principle of real time tissue elastography, illustrated here by a spring model. 
2. Methods  
2.1 Real-time tissue elastography  
The principle underlining RTE is shown in Figure 1, which indicates a spring model [Ophir 
J, 1991]. When a spring is compressed, displacement in each section of the spring depends 
on the stiffness of the spring: a soft spring compresses more than a hard spring. The strain 
distribution can be measured by spatially differentiating the displacement at each location. 
Although the tissue displacement is usually generated by manual compression and 
relaxation of the probe in practice, we were able to improve the acquisition of RTE images 
representing the distortion of liver tissue as a result of the beating of the heart or pulsing of 
the abdominal aorta. 
RTE is carried out using a high-end model of Hitachi ultrasound system (Hitachi Medical, 
Chiba, Japan). The developed software with a complex algorithm is able to process all the 
data coming from the lesion as radiofrequency impulses in a very short time and minimize 
the artifacts due to lateral dislocations, allowing accurate measurement of the degree of 
tissue distortion. We used Hitachi EUB-8500 and an EUP-L52 Linear probe (3–7 MHz; 
Hitachi Medical) for RTE. 
This system is currently commercially available for the diagnosis of mammary neoplasm. 
Patients were examined in a supine position with the right arm elevated above the head, 
and were instructed to hold their breath. The examination was performed on the right lobe 
of the liver through the intercostal space, and liver biopsy and Fibroscan were also 
performed at the same site. The RTE equipment displays two images simultaneously; one 
shows the regions of interest (ROI) as a colored area and the other indicates the conventional 
B-mode image (Fig. 2A). We chose an area where the tissue was free from large vessels and 
near the biopsy point. The measurement was fixed to a rectangle 30 mm in length and 20 
mm in breadth placed 5-10 mm below the surface of the liver (Fig. 2A). The color in the ROI 
was graded from blue (representing hard areas) to red (representing soft areas) (Fig. 2A). 
We stored the RTE images as moving digital images for 20–40 s. Ten static images captured 
by the observer at random from the moving images using AVI2JPG v6.10 converter software 
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(Novo, Tokyo, Japan) were analyzed using the novel software Elasto_ver 1.5.1,which was 
developed and donated by Hitachi Medical, on a personal computer. Numerical values of 
pixels were from 0 to 255 (256 stepwise grading) according to color mapping from blue (0) to 
red (255), and a histogram of the distribution was generated (Fig. 2B). The scale ranged from 
red for components with the greatest strain (i.e., softest components) to blue for those with 
no strain (i.e., hardest components). Green indicated average strain in the ROI, and therefore 
intact liver tissue was displayed as a diffuse homogeneous green pattern. An appearance of 
unevenness in the color pattern was considered to reflect a change in the liver stiffness. For 
quantification, all pixel data in the colored image were transferred into a histogram and 
binary image (Fig. 2B).  
 
 
Fig. 2. Procedure of image analyses for real-time tissue elastography. 
(A) The ROI was fixed to a rectangle of approximately 20-30 mm length x 20 mm breadth 
with a 400–600 mm2 area placed 5-10 mm below the surface of the liver. Left; RTE image, 
right; B-mode image. (B) The color-coded images from the ROI of RTE were analyzed by the 
software Elasto_ver1.5.1. The colors ranged from blue to red indicating the relative 
gradients from hardness to softness. Mean and Standard deviation were calculated by a 
histogram, which was generated by 256 stepwise grading derived from the color image. 
Area and Complexity were calculated from the binary image. Area was derived from the 
percentage of white regions (asterisks, i.e. hard area). Complexity was calculated as 
periphery2/Area. Median value of the data were kept as representative of RTE parameters. 
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Colored RTE images are usually classified into several patterns in the diagnosis of breast 
disease. We paid attention to the pattern change of RTE color images according to the 
progression of fibrosis. We proposed three patterns for representing the stages of liver fibrosis: 
a diffuse soft pattern, an intermediate pattern, and a patchy hard pattern (Fig. 3). The diffuse 
soft pattern indicated a homogeneously light-green colored image. The intermediate pattern 
represented a partially mottled and dotted image with blue spots on a light green background. 
The patchy hard pattern comprised mixed images with a patchwork effect of light green, red, 
and blue. Normal or minimally fibrotic liver exhibited a homogeneous RTE image that was 
colored light green (diffuse soft pattern). According to the progression of liver fibrosis, the 
homogeneous pattern transitioned to a patchy pattern consisting of a blue-colored area 
(patchy hard pattern), which may suggest a decrease of homogeneity. 
 
 
Fig. 3. Representative colored images of real-time tissue elastography according to the 
progression of liver fibrosis. 
Normal or minimally fibrotic liver exhibited a homogenous RTE image that was colored 
light green. According to the progression of liver fibrosis, the homogenous pattern 
transitioned to a patchy pattern consisting of a blue-colored area, which may suggest a 
collapse of homogeneity. A relatively homogeneous light green image indicated a diffuse 
soft pattern in RTE. A partially mottled and dotted image with blue and red spots in the 
light green background indicated an intermediate pattern. A mixed image with light green, 
blue, and red colors indicated patchy hard pattern.  
2.2 Transient elastography 
Liver stiffness was also measured by TE (Fibroscan; Echosens SA, Paris, France). Briefly, 
patients were placed in a horizontally supine position and a probe was placed on the skin 
above the right intercostal space. The velocity of shear waves, which were generated 
temporarily and passed though the liver, was combined with Young’s modulus for the 
automated calculation of elasticity [Yeh WC, 2002]. The measurement depth was between 25 
and 65 mm. The results that were obtained in ten valid measurements with a success rate of 
at least 60% and an interquartile range under 30% were considered successful. Failure was 
defined as when less than ten valid measurements were obtained. A median of 10 valid 
measurements was regarded as the liver stiffness for a given subject and expressed in 
kilopascals (kPa). 
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3. Results 
3.1 Our results 
Our results were expressed as Mean and Standard Deviation (SD), which indicates the mean 
and the standard deviation of the histogram, respectively. In another analysis, the data were 
transformed into a binary image and the results were described as Area, which indicates the 
percentage of hard tissue and represents the hard tissue domain divided by the ROI and 
Complexity (complex ratio of the shape of an extracted hard tissue domain in the ROI 
calculated as periphery2/area of the hard tissue domain). The four image features were 
calculated automatically by Elasto_ver 1.5.1 (Hitachi Medical). Mean, SD, and Complexity 
were described in arbitrary units [a.u.]. 
Figure 4 shows box plots of the RTE values corresponding to fibrosis stage in 126 patients with 
chronic hepatitis C. The Mean decreased in proportion to the increase of fibrosis score 
(Jonckheere–Terpstra test, p<0.0001). SD, Area, and Complexity increased in proportion to the 
increase of fibrosis score (Jonckheere–Terpstra test, p< 0.0001). The significant differences 
between each fibrosis stage were as follows: F1 versus F3 and F4, and F2 versus F4 for every 
parameter; F1 versus F2 and F2 versus F3 for Mean; and F3 versus F4 for Complexity (Tukey–
Kramer test, p<0.05).  No significant difference was found between the activity of chronic 
hepatitis and the fibrosis stages for any parameters (Tukey–Kramer test). The AUC of RTE 
parameters for no significant fibrosis (F0–1) and cirrhosis (F4) in 121 patients who were also 
examined successfully by TE, together with the corresponding sensitivities, specificities, and 
positive and negative predictive values are presented in Table 1. 
 
 
F1, n=62. F2, n=19. F3, n=19. F4, n=20. F scale was divided by METAVIR score. 
Fig. 4. Parameter analyses measured by real-time tissue elastography for each fibrosis stage. 
Box plots of each value of RTE corresponding to fibrosis stages F1-4. The top and bottom of 
the boxes indicate the 1st and 3rd quartiles. The length of the box represents the interquartile 
range within which 50% of values are located. The lines through the middle of the boxes 
represent the median. A) Mean, B) SD, C) Area, and D) Complexity.  
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 F=0-1     F=4  
 Mean SD Area Complexity TE Mean SD Area Complexity TE 
Cut-of 110.1 61.2 25.8 23.2 10.1 106.9 63 29.5 24.9 13.3 
AUC 0.89 0.81 0.87 0.81 0.92 0.91 0.84 0.91 0.93 0.95 
Sensitivity [%] 84.1 70.5 81.8 77.3 88.6 82.8 75.9 79.3 79.3 89.7 
Specificity [%] 82.7 73.1 80.8 75 86.5 85.1 77.6 80.6 80.6 86.6 
Accuracy [%] 83.3 71.9 81.3 76 87.5 84.4 77.1 80.2 80.2 87.5 
TE, transient elastography. 
Table 1. Results of comparisons between four image features of real time tissue elastography 
and transient elastography. 
3.2 Search results 
A PubMed search was conducted in February 2011 for full papers published in journals 
written in English in the past 5 years. The following keywords were used in combination: 
“real-time tissue elastography” and “liver”. The first author’ names, patient’s selection 
critera, patient number, and diagnostic accuracies are summarized in Table 2. The primary 
outcome was the identification of the degree of fibrosis defined as stages F1 to F4 according 
to the METAVIR score. 
Two articles were reported by Friedrich-Rust in 2007 and 2009, one article was from China, 
and three articles including ours were from Japan. Three of the articles described studies 
conducted in patients with chronic liver disease, one article limited the subjects to those 
with chronic hepatitis B, and two articles including our report included only subjects with 
chronic hepatitis C. There are two ways to calculate the results of RTE: one is the ratio of 
strain distribution between the ROI of liver parenchyma and that of other areas, and the 
other is the analysis of color images in ROI. Koizumi’s report showed the best sensitivity 
and specificity until now; 83.8 % and 90.9 %, respectively for F1, and 90.9% and 91.5 %, 
respectively, for F4. They used the ratio between the tissue compressibility of the liver 
parenchyma and that of intrahepatic small vessel. Only two articles Friedrich-Rust’s in 2009 
and ours in 2010 compared the diagnostic value of RTE with TE. Others compared the value 
of RTE with serum fibrosis markers represented by APRI.  
4. Discussion 
Liver biopsy has long been the gold standard for the assessment of hepatic fibrosis and will 
remain important in the diagnosis of liver disease with unknown etiology. However, 
because of complications, sampling error, and interobserver variability, the role of liver 
biopsy in the assessment and quantification of fibrosis in viral liver diseases is thought to be 
less valuable. Many modern noninvasive tests including serum markers and imaging 
methods are expected to become increasingly important in the near future. 
A large number of serum markers have been identified for the assessment of hepatic fibrosis. 
In clinical practice, type IV collagen 7s, type III procollagen N-terminal peptide (P-III-P), and 
hyarulonic acid are commonly utilized as direct serum markers for human liver fibrosis, 
although it is difficult to distinguish each pathological fibrosis stage using one of these 
extracellular matrix products. On the other hand, the European Liver Fibrosis (ELF) study 
reported a marker composed of the combination of P-III-P, hyarulonic acid, and tissue 
inhibitor of metalloproteinases, which achieved the diagnostic power of AUC 0.80 for Scheuer 
3-4 [Guha IN, 2008.]. Reported indirect serum markers of liver fibrosis include AAR 
(AST/ALT ratio), APRI (AST-to-platelet ratio index), Forns score, FibroTest, and the HALT-C 
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model, which are composed of several parameters commonly measured in clinical practice. 
FibroTest is currently the most carefully evaluated noninvasive serum fibrosis marker panel 
that is commercially available. FibroTest is an algorithm composed of 6 parameters, including 
haptoglobin, α2-macroglobulin, apolipoprotein-A1, γ-glutamyltransferase, bilirubin, and  
γ-globulin, and its diagnostic power for ≧F2 was reported to be AUC 0.87 [Imbert-Bismut F, 
2001.]. While the diagnostic accuracy was high, the FibroTest costs more than APRI and the 
Forns score, and requires two uncommon parameters. In APRI, using the cutoffs proposed by 
Wai et al. [Wai CT, 2003.], approximately 50% of patients could be correctly classified as 
having cirrhosis without a liver biopsy. With the Forns score, the AUC for the prediction of 
significant fibrosis (Scheuer classification, F2) was 0.86 in the test set and 0.81 in the validation 
set [Forns X, 2002]. Although direct, indirect, and combined serum marker systems consist of 
multiple biomarkers, they are all characterized by an AUC for the ROC clustering around 0.85 
in recent studies. [Afdhal NH and Curry M, 2007]. 
 
Author, year 
Patients 
selection 
Patients Control Calculation 
Fibrosis 
stage 
AUC
Sensitivity 
[%] 
Specificity 
[%] 
PPV 
[%] 
NPV 
[%] 
Friedrich-
Rust M, 2007 
viral 
hepatitis  
79 20 
elasticity score, 
stepwise 
multivariate 
logistic regression 
F=1 
F=4 
0.75
0.69 
80 
29.2 
61.1 
90.7 
63.2 
50 
78.6 
80 
Friedrich-
Rust M, 2009 
chronic liver 
disease 
134  
Japanese Elasticity 
score, 256 stepwise 
of color mapping 
F=1 
F=4 
0.64
0.63 
    
Kanamoto M, 
2009 
underwent 
an operation
41  
Elastic ratio, ratio 
of liver for the 
intercostal muscle 
F=1 
F=4 
 
96.2 
93.3 
73.3 
73.1 
86.2 
66.7 
91.7 
95 
Wang J, 2010 
chronic 
hepatitis B 
55 20 
Elastic index, 
principal 
components 
analysis 
F=1 
F=4 
0.93
0.66 
87.3 
71.4 
85 
80 
94.1 
93.8 
70.8 
40 
Koizumi Y, 
2011 
chronic 
hepatitis C 
70  
Elastic ratio, ratio 
of liver for the 
small hepatic vein 
F=1 
F=4 
0.89
0.95 
83.8 
90.9 
90.9 
91.5 
98 
83.3 
50 
95.6 
Our report 
chronic 
hepatitis C 
101 10 Mean 
F=1 
F=4 
0.89
0.91 
84.1 
85.7 
82.7 
82.9 
80.4 
46.2 
86 
97.1 
Table 2. Diagnostic accuracy of real time tissue elastography in individual studies. 
Standard US, CT, and MRI have long been used to survey liver morphology. These 
modalities are able to detect changes in the liver parenchyma when there is early cirrhosis 
and signs of portal hypertension. However, these methods are not useful to identify the 
presence of mild fibrosis. In this regard, elastography is sensitive for evaluating liver fibrosis 
based on the fact that, as the liver becomes progressively fibrotic, it becomes harder and less 
elastic. The technique based on US and MRI easily and noninvasively measures the relative 
values of liver stiffness. TE has been used most frequently worldwide and has established a 
role in clinical practice for detecting advanced fibrosis instead of liver biopsy. A pioneering 
report from Castera in 2005 showed that the AUC of TE was 0.84 for the diagnosis of F1 and 
0.94 for the diagnosis of cirrhosis. Although MR elastography (MRE) was shown to be 
superior to APRI and TE for determining the stage of fibrosis in patients with underlying 
liver diseases [Huwart L, 2008], MRE cannot be performed on patients with an iron 
overloaded liver because of background noise. In addition, MRE takes more time and costs 
more than the US-based elastographies. 
www.intechopen.com
 
Liver Biopsy 
 
248 
Four published reports have compared the diagnostic accuracy of RTE with serum markers 
including APRI. RTE was shown to be superior to APRI in determining the stage of liver 
fibrosis in all of these studies except for the first report by Friedrich-Rust in 2007. It is 
believed that the more sensitive probes have been developed which could mitigate the deep 
attenuation of the ultrasound image and without requiring external stress. Accordingly, we 
were able to avoid the influence of the liver surface inside the ROI which is hard and 
therefore assessed as a harder area and to improve the acquisition of the color image 
representing the distortion of liver tissue due to the heartbeat or the pulse of the abdominal 
aorta without interobserver variability. 
Although Friedrich-Rust (2009) reported that RTE was inferior in determining the stage of 
liver fibrosis compared to TE, our results presented in Table 1 indicated that the 
performance of RTE compares favorably with that of TE for detecting the degree of liver 
fibrosis in patients with chronic hepatitis C. TE has been reported to have several limitations 
and disadvantages in evaluating patients with obesity and ascites. In fact, in our study, we 
achieved successful evaluation of all patients with RTE, while five patients (F1, 2; F3, 1; F4, 
2) failed to receive TE measurements due to obesity and liver atrophy. Koizumi also 
reported that RTE could be employed in patients with BMIs greater than 30 kg/m2. 
Although the results from RTE were conducted by the image of color map, the results were 
calculated by either the ratio of strain distribution between ROI of the liver parenchyma and 
that of another area or by the image analysis of ROI. The method of Kanamoto which was 
used intercostal muscle as the reference for the ratio was inferior to the other method, since 
the area is considered to be influenced by instability of tissue distortion of subcutaneous fat 
and by the liver surface which is one of the hardest areas in liver parenchyma. In contrast, 
Koizumi adopted the hepatic vein as a reference and obtained the best sensitivity and 
specificity for characterizing the stage of fibrosis in related articles. Other studies utilized 
image analysis using exclusive software and reported different results. Thus the best 
method for the analysis and unit of RTE remains unclear, but may be revealed by future 
multicenter studies using larger patient cohorts.  
In the future, the combination of image modalities with serological parameters will further 
improve the accuracy in differentiating fibrosis stages. Interestingly, Castera reported that 
the best results were achieved by a combination of TE with the FibroTest. Although acoustic 
radiation force impulse, which is a most recent technology, TE, and MRE are all based on 
shear wave propagation, RTE is constructed by an original theory which is based on tissue 
distortion. Friedrich-Rust reported in 2007 that the best diagnostic accuracy was obtained by 
combining the variables used for the calculation of the RTE elasticity score with the platelet 
count and GGT.  
Elastography will be applicable to the screening of hepatocellular carcinoma (HCC) and the 
complication of cirrhosis. In the METAVIR and Desmet’s histological scoring systems, 
cirrhosis is classified as a single category, F4. However, the degree of fibrosis that indicates 
the amount of extracellular matrix materials including collagen that may be closely 
associated with the function of hepatocytes and portal hypertension may vary among 
patients with cirrhosis. Foucher reported in 2006 that liver stiffness (kPa) measured by TE in 
cirrhotic patients correlates well with clinical parameters indicating the severity of cirrhosis; 
27.5 kPa was the cutoff value for the presence of esophageal varices stage 2 or 3, 37.5 kPa for 
liver function Child B or C, 49.1 kPa for a past history of ascites, and 62.7 kPa for bleeding 
from esophageal varices. Masuzaki prospectively observed that, in 866 patients with chronic 
hepatitis C, HCC developed in 77 cases within 3 years of observation, and 0.4% of HCC was 
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detected in patients whose liver stiffness at entry was less than 10 kPa and 38.5% of it was 
more than 25 kPa, indicating the usefulness of liver stiffness measurement as a tool for 
predicting the development of HCC. Because RTE is expected to stage cirrhosis in greater 
detail with clinical relevance, it may be useful for detecting and assessing the risk of 
cirrhotic complications and the development of HCC. 
Although noninvasive assessment of liver fibrosis is already established in patients with 
chronic hepatitis C, it is still necessary to improve assessment in other highly prevalent 
diseases, such as non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NASH). We 
reported that the AUC of AAR, age-platelet index, APRI, and cirrhosis discriminant score 
for predicting cirrhosis were 0.81, 0.87, 0.79, and 0.95, respectively, in 50 patients with 
NASH and 0.56, 0.65, 0.76, and 0.78, respectively, in 100 patients with chronic hepatitis C 
[Fujii H 2009]. RTE will be expected to play a major role in elastography for these patients, 
since it is not influenced by obesity or BMI.  
5. Conclusion  
We have described a convenient and noninvasive procedure, RTE, for the visual assessment 
of liver stiffness. The performance of RTE compared favorably to TE for detecting the degree 
of liver fibrosis in patients with chronic hepatitis C. We suggest that RTE could also be used 
as a routine imaging method to evaluate the degree of liver fibrosis in patients with liver 
diseases other than chronic hepatitis C. Future studies on larger patient cohorts will be 
necessary for the validation of RTE analysis, and the combination of RTE parameters with 
other clinical values including serum biomarkers will enable improvement of accuracy in 
assessing hepatic fibrosis. 
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